3 Facts About Semaglutide For Weight Loss 🍽️✨ FDA: In June 2021, FDA approved semaglutide under the brand name Wegovy for chronic weight management in adults with obesity or overweight individuals with at least one weight-related condition. Clinical Trials: A study of 1,961 adults by the New England Journal of Medicine compared people using semaglutide plus a diet and exercise program with people who made the same lifestyle changes without semaglutide. After 68 weeks, half of the participants using semaglutide lost 15% of their body weight, and nearly a third lost 20%.Participants who incorporated only lifestyle changes lost about 2.4% of their weight. Long-Term Benefits: In addition to weight loss, semaglutide has been associated with improvements in other health markers, such as reduced blood pressure, improved cholesterol levels, and decreased risk of type 2 diabetes. #healthy #happy #AppetiteControl #SemaglutideClinicalStudies #weightloss #medicalweightloss #semaglutide #tirze...